Coya Therapeutics Inc Sustainability Reports
Coya Therapeutics, Inc. is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and therapeutic advantages of regulatory T cells (Tregs). Its therapies target systemic inflammation and neuroinflammation across neurodegenerative, autoimmune, and metabolic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00Z4HBCC8
1 reports from 2023 to 2023
Company Profile
Coya Therapeutics, Inc. is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and therapeutic advantages of regulatory T cells (Tregs). Its therapies target systemic inflammation and neuroinflammation across neurodegenerative, autoimmune, and metabolic diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
